Inhibrx, Inc. (INBX) Misses Q1 EPS by 26c

Inhibrx, Inc. (NASDAQ: INBX) reported Q1 EPS of ($1.12), $0.26 worse than the analyst estimate of ($0.86).

For earnings history and earnings-related data on Inhibrx, Inc. (INBX) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Ubiquiti (UI) Tops Q4 EPS by 25c, Beats on Revenue
• Vireo Growth completes acquisition of C21 Investments